4//SEC Filing
Dilmore Jillian 4
Accession 0001062993-22-015126
CIK 0001780097other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:11 PM ET
Size
450.3 KB
Accession
0001062993-22-015126
Insider Transaction Report
Form 4
Baudax Bio, Inc.BXRX
Dilmore Jillian
Corporate Controller/SecretaryOther
Transactions
- Award
Common Stock
2022-06-15+15,467→ 15,738 total
Footnotes (1)
- [F1]Each Restricted Stock Unit ("RSU") is the economic equivalent of one share of Baudax Bio, Inc. (the "Company") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest 50% on June 15, 2023 and 50% on June 15, 2024, in each case subject to continued service with the Company through the applicable vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the applicable vesting date.
Issuer
Baudax Bio, Inc.
CIK 0001780097
Entity typeother
Related Parties
1- filerCIK 0001923107
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:11 PM ET
- Size
- 450.3 KB